Navigation Links
KaloBios' KB001 Anti-Pseudomonas Antibody Study Published in Pediatric Pulmonology
Date:9/18/2013

A, KB003 and KB004  and the potential for KB001-A to be a non-antibiotic treatment to reduce airway inflammation and tissue damage in CF patients with chronic Pa infection. Forward-looking statements reflect management's current knowledge, assumptions, judgment and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, they give no assurance that such expectations will prove to be correct and you should be aware that actual results could differ materially from those contained in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties including, but not limited to, the company's limited cash reserves and its ability to obtain additional capital on acceptable terms, or at all, including the additional capital which will be necessary to complete the clinical trials that the company has initiated or plans to initiate; the company's dependence on Sanofi Pasteur for the development and commercialization of KB001-A; the company's ability to successfully complete further development of its programs; the uncertainties inherent in clinical testing; the timing, cost and uncertainty of obtaining regulatory approvals; the company's ability to protect the company's intellectual property; competition; changes in the regulatory landscape or the imposition of regulations that affect the company's products; and other factors listed under "Risk Factors" in the company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 1, 2013 and the company's other filings with the Securities and Exchange Commission.

All forward-looking statements are expressly qualified in their entirety by this cautionary notice.  You are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this release.  The company has no obligation, a
'/>"/>

SOURCE KaloBios Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. KaloBios Pharmaceuticals Announces Pricing of Initial Public Offering
2. KaloBios Pharmaceuticals Completes Initial Public Offering
3. KaloBios Presents Clinical Results with Anti-GM-CSF Antibody in Persistent Asthma Data from KB002 Phase 1/2 Study Presented at the American Academy of Allergy, Asthma and Immunology Meeting
4. KaloBios Presents Clinical Results with Anti-GM-CSF Antibody in Persistent Asthma
5. Bioassociate Announces Initiation of Coverage on KaloBios Pharmaceuticals, Inc.
6. KaloBios to Present at Future Leaders in the Biotech Industry Conference
7. KaloBios Targeted Antibacterial KB001-A to be Featured in BIO 2013 Panel Discussion of "New Defenses Against Old Enemies"
8. KaloBios to Present at Needham Healthcare Conference
9. KaloBios Reports First Quarter 2013 Financial Results
10. KaloBios to Present at Stifel Healthcare Conference 2013
11. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/16/2014)... 16, 2014 Eight finalists, all representing outstanding ... present their proposals for a chance to compete for ... Sheikh Zayed Institute Second Annual Pediatric Surgical Innovation Symposium ... on Friday, Oct. 24, 2014. Selected from ... the US and internationally, the finalists are: ...
(Date:10/16/2014)... 16, 2014 Curtis & Coulter LLC, a ... away from hosting their co-located Bioequivalence: Intersection Between ... Formulation Innovations Summit taking place on November 5-6 ... November,s events are specifically designed ... the bioequivalence testing process, as well as optimizing formulation ...
(Date:10/16/2014)... 2014  Personna Industrial, the world,s leading manufacturer of ... and safety systems will be exhibiting at the MD&M ... on October 29-30th. Personna Industrial,s booth is #847. MD&M ... for medical device design and manufacturing professionals. The MD&M ... and applications that are redefining the medical device manufacturing ...
Breaking Medicine Technology:Finalists for Children's National Health System pediatric medical device competition announced 2Finalists for Children's National Health System pediatric medical device competition announced 3Finalists for Children's National Health System pediatric medical device competition announced 4Simplifying the Bioequivalence Testing Process and Optimizing Oral Formulation Development via Unifying the Global Life Science Community this November in San Diego 2Personna Industrial Exhibiting Among Top Suppliers To Medical Industry At MD&M Minneapolis 2
... public health, and regulatory highlights for this week from ... document is designed for credentialed journalists. Release dates and ... 2011. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... any regulatory or enforcement actions due to legal limitations. ...
... YORK,  June 6, 2011 Aeolus Pharmaceuticals, Inc. (OTCQB: ... is available for on-demand viewing. LINK: ... button. Aeolus Pharmaceuticals, presentation will be available ... the "virtual trade booth" for the next three weeks. ...
Cached Medicine Technology:FDA News & Notes - Week of June 6, 2011 2Aeolus Pharmaceuticals, Inc. Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com 2
(Date:10/18/2014)... October 19, 2014 Mercy’s student mentoring ... report on programs that help college students succeed. ... software and services, published the recent paper, “Retention and ... and Mercy is one of six higher education institutions ... fall to fall retention rates for first-time, full-time students ...
(Date:10/18/2014)... (PRWEB) October 19, 2014 Recently, BamboofloorChina.com, one ... market, has added a new assortment of bamboo floorings ... offering huge price cuts for worldwide clients now, up to ... of useful and durable items for sale now; most of ... decades. Clients can find more than 100 different kinds of ...
(Date:10/18/2014)... October 2014 All humans have a natural opioid system ... ECNP Congress in Berlin, has found that the opioid ... normal healthy volunteers. The work was carried out by ... and was funded by the Medical Research Council. This ... Neuropsychopharmacology congress in Berlin., Gambling is a widespread behaviour ...
(Date:10/18/2014)... NY (PRWEB) October 18, 2014 Ticket Down is ... prices have eased considerably for this year's World Series. ... in the World Series this year. This determined team has ... The San Francisco Giants have had better luck in terms of ... 2010, 1954, 1933, 1922, 1921 and 1905. This team ...
(Date:10/18/2014)... 18, 2014 Market Research ... Industry, 2009-2019 is a professional and in-depth ... Chondroitin sulfate industry. The report firstly reviews ... its classification, application and manufacturing technology. The ... manufacturers of Chondroitin sulfate listing their product ...
Breaking Medicine News(10 mins):Health News:Mercy’s PACT Student Mentoring Program Recognized for Helping College Students Succeed 2Health News:Brand New Bamboo Floorings Now Unveiled By BamboofloorChina.com, A Distinguished Supplier In The Market 2Health News:Pathological gambling is associated with altered opioid system in the brain: Reduced feeling of euphoria when compared to healthy volunteers 2Health News:2014 World Series Tickets: Giants vs. Royals World Series Ticket Prices Have Eased Substantially 2Health News:Chondroitin Sulfate Industry Global & Chinese Forecast to 2019 Now Available at RnRMarketResearch.com 2Health News:Chondroitin Sulfate Industry Global & Chinese Forecast to 2019 Now Available at RnRMarketResearch.com 3Health News:Chondroitin Sulfate Industry Global & Chinese Forecast to 2019 Now Available at RnRMarketResearch.com 4
... Israel, Nov. 29 Elbit Imaging Ltd.,(TASE, Nasdaq: ... November,28, 2007, InSightec Ltd. ("InSightec"), a subsidiary of ... an agreement for an internal,round of financing in ... existing,investors, namely: Elbit Ultrasound (Netherlands) B.V., a fully ...
... Satellite Newsfeed Notification ... Friday, 11/30, WASHINGTON, Nov. 29 , ... more than 19,million Americans. Despite its prevalence, depression ... is a,first-of-its-kind study examining the statistical relationship between ...
... benefit for the female hormone , THURSDAY, Nov. 29 ... which is often given with estrogen in hormone replacement ... U.S. researchers say. , They conducted tests on female ... come to this conclusion. , Treatment with estrogen blocked ...
... Week to Experience the, World,s Most Advanced Laparoscopic Surgery ... ... Congress, CLEVELAND, Ohio, November 29 Simbionix unveiled the,latest module ... Global Congress of Minimally Invasive Gynecology., The LAP Mentor(TM) multidisciplinary ...
... Utah, Nov. 29 Nutraceutical,International Corporation (Nasdaq: NUTR ... and year ended September 30, 2007., Net sales ... to $35.7 million for the same quarter of fiscal ... or $0.23 diluted earnings per,share, compared to net income ...
... 29 InSightec Ltd. today,reported that it has closed ... existing investors: Elbit Imaging Ltd. (Nasdaq: EMITF ), ... Company,(NYSE: GE ), MediTech Advisors LLC ("MTA"), a ... managers of the company., The investment will take ...
Cached Medicine News:Health News:Elbit Imaging Ltd. Announces US$19,829,643 Investment in its Subsidiary InSightec Ltd., in an Internal Round of Financing 2Health News:Elbit Imaging Ltd. Announces US$19,829,643 Investment in its Subsidiary InSightec Ltd., in an Internal Round of Financing 3Health News:Elbit Imaging Ltd. Announces US$19,829,643 Investment in its Subsidiary InSightec Ltd., in an Internal Round of Financing 4Health News:Ranking America's Mental Health: An Analysis of Depression Across the States 2Health News:Ranking America's Mental Health: An Analysis of Depression Across the States 3Health News:Progesterone Won't Shield Women Against Alzheimer's 2Health News:Gynecologists Get First Hands-On Experience With Simbionix LAP Mentor(TM) 2Health News:Nutraceutical Reports 2007 Fiscal Year End Results 2Health News:Nutraceutical Reports 2007 Fiscal Year End Results 3Health News:Nutraceutical Reports 2007 Fiscal Year End Results 4Health News:Nutraceutical Reports 2007 Fiscal Year End Results 5Health News:Nutraceutical Reports 2007 Fiscal Year End Results 6Health News:InSightec Ltd. Announces US$30 Million Investment Round 2Health News:InSightec Ltd. Announces US$30 Million Investment Round 3
Digital Ultrasonic Diagnostic Imaging System...
...
Pefakit PiCT DxS Diluent for Determination of Total Heparin...
Quantitative Plasma-based Factor XIII Incorporation Assay Kit...
Medicine Products: